2024 GRANTS Program Opens Call for Proposals

Growing Research and New Technology for Swine (GRANTS) program logo

Boehringer Ingelheim–sponsored program funds research geared at improving swine health and production


DULUTH, Ga. (Jan. 2, 2024) — Proposals are now being accepted for the 2024 cycle of the Growing Research and New Technology for Swine (GRANTS) program, sponsored by Boehringer Ingelheim. Practicing veterinarians and producers, as well as researchers and academics, can apply for one of three $35,000 awards for research related to swine health and production.  

Following the expansion of the program’s focus in 2022, GRANTS funds field-applicable research into a wide variety of topics related to swine health and production, from respiratory, reproductive and enteric diseases to new technologies, diagnostics and overall approaches to supporting pig health and performance. 

The submission period is open from December 15 – March 15, with the final deadline to apply being Friday, March 15, 2024. Research proposals must have the potential to generate new information or approaches for controlling and managing swine diseases, or inspire broader industry innovation. Proposals will be reviewed and judged by the Swine Research and Technology Review Board, which consists of seven independent swine veterinarians and researchers.   

“Research is an invaluable tool for our industry, uncovering new opportunities or breakthrough approaches, and charting a course for critical advancements in swine health and production,” said Reid Philips, DVM, PRRS Technical Manager at Boehringer Ingelheim U.S. Swine Division. “The funding through the GRANTS program helps us prioritize the field-applicable research that will drive positive change in our industry for years to come.”  

For more than 20 years and across multiple evolutions of this program, Boehringer Ingelheim has provided more than $1.8 million in funding for more than 70 research projects, supporting the development of less costly, innovative diagnostic testing and sampling processes; identifying more effective biosecurity practices; helping the industry better understand key diseases; and developing risk assessment tools, intervention programs and vaccination strategies.  

For more information on the GRANTS program, including how to apply, please visit http://www.swineresearchawards.com


About the Swine Research and Technology Review Board 

The Swine Research and Technology Review Board, an independent group of swine veterinarians and researchers, selects GRANTS recipients annually. Board members for the 2024 award selection process include: 

  • Montse Torremorell, DVM, Ph.D., University of Minnesota 

  • Darin Madson, DVM, Ph.D., Iowa State University, Veterinary Diagnostic Lab 

  • William Hollis, DVM, Carthage Veterinary Service, Ltd. 

  • Emily McDowell, DVM, Pipestone Veterinary Services 

  •  2024 AASV Young Swine Veterinarian of the Year 

  • 2024 AASV President-elect  

  • 2025 AASV President-elect 


About Boehringer Ingelheim Animal Health USA 

Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers, and governments in more than 150 countries, we offer a large and innovative portfolio of products and services to improve the health and well-being of companion animals and livestock.  

As a global leader in the animal health industry and as part of the family-owned Boehringer Ingelheim, we take a long-term perspective. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Pharma businesses and by delivering value through innovation, we enhance the health and well-being of both.   

Boehringer Ingelheim Animal Health has deep roots in the U.S. From a start in St. Joseph, Missouri, more than 100 years ago, it has grown to encompass seven sites. Boehringer Ingelheim Animal Health’s portfolio contains widely used and well-respected vaccines, parasite-control products and therapeutics for pets, horses and livestock.  

Learn more about Boehringer Ingelheim Animal Health USA at bi-animalhealth.com


Media Contacts  

Lauren Housh  

PR Supervisor  


(302) 632-3661  



Beth Breeding   

Corporate Communications, Boehringer Ingelheim Animal Health  

(703) 946-0370  



©2024 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved.  US-POR-0219-2023-A